Wednesday, March 17, 2010

Final Response

Despite ethical controversy, human embryonic stem cells are the medical treatment of the future but are unsafe to practice at this time; instead, we should expand the practice of regular human stem cells around the world because they are currently able to treat previously incurable conditions.

Two people that inspired me during my research are Arndt Roehlig and Dr. Shimon Slavin. My interviews with both people helped me to form my thesis because they were able to give me their personal insight to the stem cell field. The interview with Arndt Roehlig was very inspiring because he has received stem cell therapy treatments for his Multiple Sclerosis. I was able to gain a new perspective on the process of stem cell treatment, and also have a first hand source as to how the treatment can impact a life. When I learned that 90% of Arndt Roehlig's symptoms had been relieved because of the therapy, it solidified my opinion that stem cell therapies should be available everywhere.

The X Cell Center website also contributed to my research. The X Cell Center is overseas and these treatments are not available in the US. The X Cell Center website had lists of commonly treated diseases (using stem cell therapies), including Alzheimer's. The wide range of conditions that the X Cell Center is able to treat amazed me and made me wonder why isn't this available in the US? I look forward to seeing stem cell therapies being widely practiced in the US, but from my research, it looks like it could still be years. Although that's disappointing, the accomplishments X Cell Center has made opened my eyes to just how many conditions are treatable with stem cells.

A turning point in my research would have to be the first interview I conducted with Arndt Roehlig. By that time I had learned enough about stem cell therapies to be able to ask him about his personal experience, but I also realized there were a lot of holes in my research and more that I needed to learn. As a result, the interview was mediocre. However, it helped me to learn what I needed to know more about and be able to go and find the information. Between the first and second interview with Arndt Roehlig I was able to fill many of the gaps and conduct a much better interview. The responses I received were just what I had been looking for and also helped me form an opinion about human embryonic stem cell usage. Arndt said that he thinks hESCs should be available to those who need them, and as long as they are helping people ethical controversy shouldn't be an issue. A CNN video interview with Dr. Francis Collins also helped me to be more comfortable with the idea of hESCs and helped me form my own opinion. Dr. Francis Collins is a strict Christian, but he believes that hESCs are going to help people, and also clarified that the embryos are donated and would otherwise be destroyed.

The interview I conducted with Dr. Shimon Slavin pushed me in yet another direction and helped me make my final thesis. Dr. Shimon Slavin is very well respected and is a pioneer in stem cell research. I respect his opinion very much, which is why I had to change my thesis once again. A side of hESCs that I had not read about was how even though they can do extraordinary things, they are not yet safe to use in therapies, Dr. Slavin addressed this when I asked him about hESCs. While the change in my thesis is subtle, my opinion of hESCs has changed greatly. This is an example of how the blog was constantly adapting and changing right up to one of the last posts. I'm pleased that I chose to research stem cells (both adult and embryonic) because it opened up a new field that I might pursue as a career. I still enjoy learning about stem cells, and creating this blog was never dull, I will continue to research stem cells outside of this project.

Saturday, March 13, 2010

Response: Interview with Dr.Slavin 16

I can't say how excited I am to have had the opportunity to interview Prof. Shimon Slavin. He is a pioneer in stem cell research and developed stem cell therapies that are used world wide. His efforts are changing many lives and are even going as far as treating cancer and other conditions. This interview has changed my opinion, once again on hESCs. I believe I'm going to have to change my thesis once more to accommodate my new opinion. I'm not saying I think hESCs are bad. I just don't think they are as wonderful as I had begun to perceive them. I'm grateful for this interview and respect Prof. Slavin's opinions. My interpretation of his response to the question about hESCs is that he doesn't approve of their usage, that he thinks poorly of the doctors who use them. Prof. Slavin does not think hESCs are safe to use and all doctors who use them are endangering their patients. My opinion now is that hESCs are going to become a valuable form of medicine, but for right now, stem cells will do fine and we shouldn't push hESCs until they are completely safe if we don't have too.

Sunday, March 7, 2010

Response: Interview Questions For Prof. Slavin

Dear Emily,


Here are some answers to your questions:


  1. I have been practicing medicine since 1967. As soon as I finished my studies and internship I joined compulsory service in the navy and was the doctor of the frogman unit.
  2. I practice mostly cell therapy and immunotherapy that is to say, using cells (hematopoietic stem cells, lymphocytes, mesenchymal stromal stem cells etc) in order to treat patients in need with nature's own tools. Mostly I am recognized as an expert in the field of stem cell transplantation for curing hematological malignancies, genetic diseases, diseases caused by deficiency of bone marrow products etc. More recently the use of stem cell transplantation has been extended to a treatment of certain types of other cancers as well as life threatening autoimmune diseases.
  3. Indeed, cell therapy is exciting mostly because using such innovative modalities we can cure patients considered incurable by any other method. I started to study the role of stem cells first in experimental animals at Stanford University in 1975-1978 and then practiced stem cell transplantation at the Fred Hutchison cancer center in Seattle, Washington. I then developed new procedures for bone marrow transplantation based on better immunosuppression for prevention of rejection of donor bone marrow cells and subsequently came up with new ideas on how to use donor lymphocytes to kill cancer cells that are resistant to chemotherapy and radiation, a procedure known as donor lymphocytes infusion (DLI). The first case of DLI treatment was in December 1986 with a 2.5 year old boy who was considered incurable after a failed treatment with allogeneic stem cell transplantation and he was cured (still alive and well today, >20 years out) thus proving for the first time that lymphocytes can be more effective than any aggressive anti-cancer modality known.
  4. I began research when I was in high school and then during the last years of med school and even today, as a qualified doctor, I am always involved in basic and clinically applied research trying to apply innovative modalities at the patient bedside.
  5. DLI is a procedure started by me. Initially everyone was skeptical and couldn't believe that such a simple maneuver could cure patients that were otherwise resistant. Despite initial skepticism subsequently many people reproduced my work, and claimed they invented it... Many of them receive more recognition and awards than me but that is fine. The role of lymphocytes in eliminating undesirable host cells was the main concept that led to non-myeloablative stem cell transplantation. Although the concept was that in order to cure cancer the patient must receive maximally tolerated doses of chemotherapy and radiation in an attempt to physically kill all cancer cells and use the transplant as a rescue procedure, my concept in view of the above was that the role of transplant is mostly to achieve host-versus-graft tolerance and once tolerance is established donor lymphocytes can be permanently accepted and then they have an ample amount of time to do their job: elimination of undesirable malignant cells of the host.
  6. The most common diseases that we can treat successfully with immunotherapy by allogeneic lymphocytes are all the hematological malignancies. Some of them respond better than others (for example: chronic myeloid leukemia).
  7. I specialize in all forms of stem cell therapy including autologous stem cell transplantation, allogeneic stem cell transplantation from a matched donor, matched unrelated donor, cord blood stem cells and half-matched family donors. We are using transplants also of an enriched sub-population of stem cells known as mesenchymal stromal stem cells (MSC) because such cells are very [XXX cut off XXX].
  8. CTCI is a new center, 2 years old. We treat several patients every day and our focus is personalized treatment and as such we devote each patient a lot of time because every patient is different and every cancer is different and therefore treatment cannot be the same and all the new principles must be well explained to the patient and their treating physician.
  9. We never use embryonic stem cells for cell therapy. It is too early to do so because of many unsolved problems and anyone who does so at present time should be considered a charlatan.
  10. My most memorable case is the boy who was first treated with DLI. He was cured and following his treatment a new concept was introduced in medicine and now thousands of patients all over the world owe their lives to this little child. We have other memorable cases as well, such as one Filipino girl treated at the age of 12 who is now a doctor 16 years later and she was the first one to prove that activated lymphocytes can cure cancer even without stem cell transplantation provided that patient is treated at the state of minimal disease. Another remarkable case we had that may change history of medicine in that particular field was the first case of successful gene therapy of severe combined immune deficiency. This is a disease that is sometimes called bubble baby disease because patients are born without an immune system and are susceptible to infections and cancer. We could show using a new approach that gene therapy could be used to cure such patients following our successful first case additional cases were done in Italy and all of them showed remarkable response to treatment using the same method used to treat the first child. We have additional modalities but I think it is enough for now.
  11. Cancer immunotherapy is using the immune system to fight cancer.
  12. Innovative treatment takes time to be expanded to other centers. Most doctors are initially very skeptical and it takes many years to receive meaningful and conclusive results. Unless such results are obtained colleagues are always skeptical and therefore, unfortunately, many patients in need cannot benefit from innovative treatment simply because their treating physicians are not aware of innovations in medicine.


I hope this information was useful, best luck to you on your project.


Sunday, February 28, 2010

Interview Questions for Prof. Slavin

1.) How long have you been practicing medicine?

2.) What field of medicine do you practice in and why did you choose to practice in this field?

3.) You're work with cell therapy is groundbreaking and helping so many people, when did you begin working with/developing cell therapies and why?

4.) How much research and schooling did you need to have before you were prepared to develop your first cell therapy?

5.) Was a cell therapy a fairly new concept when you began working with cell therapy of cancer by donor lyphocyte infucions, post allogeneic stem cell transplantation, and nonmyeloablative stem cell transplantation?

6.) I'm unfamiliar with these treatments, what is the most common disease that each treats and how what are the steps of each treatment?

7.) Do you specialize in any type of stem cell therapy? If so, what kind and who are the typical canidates to recieve this therapy?

8.) On average, how many patients does CTCI treat each year?

9.) Have you ever used human embryonic stem cells for a cell therapy? If so, what was the therapy treating?

10.) What is one of your most memorable cases that you've had as a doctor? How was it treated, and was the treatment a success?

11.) Your website says that CTCI is the Internation Center for Cell Therapy and Cancer Immunotherapy, can you explain to me what Cancer Immunotherapy is?

12.) How long did it take for your therapies to be used worldwide?

Thursday, February 25, 2010

Response: Stem Cell Approvals 15

I think it's terrific that the FDA and NIH are making an effort to get breakthroughs such as stem cell therapies out and available to the public. The article did not mention any kind of stem cells in particular, so I'm curious as to which type they were referring to. Stem cells in general? Adult stem cells? Human embryonic?

This particular article didn't even brush on the ethical controversy of stem cell therapies. It was more focused on the politics of the situation with the FDA and new breakthroughs in general. I was pleased to find out that stem cells will be one of the focuses in developing breakthroughs.

I hope to hear more soon about which areas are awarded the grant money and if stem cell therapy development will receive any of the $6.75 million. In a previous article, California received grants specifically aimed to benefit stem cell research, both adult and embryonic.

For the FDA to be making this kind of contribution is exciting. Stem cell therapies are a very up and coming procedure and hopefully will not be over looked when the grants are awarded to avoid controversy.

Notes: Stem Cell Approvals 15

• Stem cell therapies are a medical treatment that US officials (FDA) is very interested in further evaluating.

• February 24, 2010 in an effort by the FDA and National Institute of Health (NIH) 6.75 million dollars are being made available in grants for the progression of medical research, specifically turning potential treatments into options available to the public.

• Health and Human Services Secretary, Kathleen Sebelius says "We want to accelerate and illuminate the pathway from microscope to market," something that would be incredibly influential to make stem cell therapies available in the US. "For Americans this is going to mean that new treatments are safer and available sooner."

• President Obama proposed a $4.03 billion budget to the FDA for the fiscal year.

• A new panel is being made to evaluate new leaps and discoveries for the FDA and will include 6 senior scientists from a collaboration of agencies.

Friday, February 19, 2010

Parent comment

BLOG COMMENT

MY NAME as author of the blog: Emily Whitaker
TITLE OF MY BLOG: New and Developing Stem Cell Research
NAME OF PERSON WITH WHOM I SHARED MY BLOG: Colleen Whitaker
RELATIONSHIP OF PERSON TO ME: Mom
DATE I SHARED MY BLOG: February 18, 2010

COMMENTS FROM RELATIVE WHO LISTENED TO MY EXPLANATION AND READ MY BLOG:

After reading the blog entry in it’s entirety, I can say how interesting it was to watch the authors knowledge and opinions grow and change as the writings progressed. I felt as if even though I, as learning about the vast subject of stem cell research and all it entails, the author was also learning right along with me. Her personal progression was just as interesting as the blog itself. The topic is fascinating and could and may potentially affect all of us in one way or another in our lifetime.

The interview was the most impressive of all the aspects of the blog. It gave the blog a personal approach not just a researchers perspective or interested party but a human element.

Emily’s blog was educational, informative and interesting. I wanted to read more when I was finished with her final entry. That is a sure sign of a solid topic and skilled writer. The only errors I found were it was hard to read with the changes to the font. I also found some minor spelling errors but they were minimal considering the length and number of entries in the blog. She clearly feels passionate about this topic and that took over which perhaps lead to the errors. I found that most errors mentioned were corrected, like the consistency of the font, in her newer entries.

Perhaps one suggestion I have for Emily is to give definitions to words or medical terms used immediately in the blog when used, maybe within parenthesis directly following the term or word.

C.Whitaker


Sunday, February 7, 2010

Response: Ardnt Roehlig interview 2. 14

I was so pleased to have the opportunity to interview Arndt Roehlig again. It's been nearly a year since he received his stem cell therapy in Istanbul, and he's already looking forward to a new generation of treatment from Dr. Slavin. As a part of the interview, Roehlig gave me Dr. Slavin's e-mail address. I'm looking forward to hopefully having the chance to interview him as well.

I think it's very interesting that Dr. Slavin has already developed a new generation of stem cell therapy and it's already going through regulations and such in Istanbul as well as Athens.

I highly appreciate the insight Arndt Roehlig's given me from his first hand knowledge of stem cell therapy. I wasn't sure what to expect when I asked his opinion on hESCs. Everyone has their own opinion, and the two opinion's I've found are two different extremes.

Arndt Roehlig said that he thinks if hESCs are going to help someone who's sick, that they should use them. Although Roehlig himself has not received hESCs therapy, I'm sure he's very aware of the clashing ethical opinions. On one side you have 'help the already living" and on the other you have "don't destroy what could have been a person." I'm still slightly conflicted, but I'm leaning more toward the use of hESCs now that I have more research.

Notes: Ardnt Roehlig interview 2. 14

1. What kind of stem cell therapy did you receive? Bone marrow derived mesenchymal stromal cells (MSC)


2. Who is Dr.Slavin? Which of his quotes helped you reach your decision to receive your treatment? "The secret is to do the treatment of choice in the early stages of the disease before irreversible changes occur,"


http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20081116/ms_treatment_081116/20081116/

Shimon Slavin, M.D.
Professor of Medicine
Scientific & Medical Director
The International Center for Cell Therapy & Cancer
Immunotherapy (CTCI)
Top
Ichilov at the Weizman Center,
Tel
Aviv Medical Complex
14
Weizman Street
Tel
Aviv 64239, ISRAEL
slavin@CTCIcenter.com


3. Are you opposed to human embryonic stem cell (hESC) research? What is your opinion of hESCs? If it helps the patient, absolutely not. If you are sick and it will help you, then you should be able to receive treatment. This is a political question, as soon as the person who is against this needs this kind of help, all of the sudden they are for it and try to find a way to jump the line to be first.


4. Have you noticed a difference in your condition since the last interview? My condition is up and down, but from 100% of the speed of progression prior to infusion, I believe I’m now somewhere at 10-20% of that speed of progression.


5. How long ago did you receive your stem cell therapy in Istanbul? March 6, 2009.


6. You mentioned trying the next generation of Dr.Slavin's treatment, what will this entail? Will you have to go back to Istanbul? What are the differences between the new generation treatment and the treatment you received? When will you be able to receive this treatment? This treatment will target even more cell growth, but is in testing and approval stage with the Israeli government at this time, so not yet available. Istanbul or Athens. It is not known yet, as Dr. Slavin has told me to wait a full year to asses the progression of my disease.


7. Why did you agree to have your story posted on scienceblog.com? If I’m going to be a guinea pig, I might as well share my experience.


8. How has this treatment effected your daily life? I am grateful for it as I still have some ability as compared to where I would have been with out treatment.


9. Is there anything else you would like to add about your personal opinions/experiences regarding stem cell treatments? I think we are on the cusp of finding something successful.


Thursday, February 4, 2010

Excellent research!

I am fascinated by what you are finding because of your willingness to put a solid effort into your research. Your information about the xcell website and the work that is being done in Germany is eye-opening. Even Alzheimer's responding to stem cell therapy - amazing! Keep up the outstanding work . . . !

Wednesday, February 3, 2010

Response: difference between adult stem cells and hESCs 13

This article was the perfect background information I had been looking for. There were basic pros and cons of hESCs and adult stem cells, as well as clearly stated differences. I am aware that these pros, cons, and differences might be altered since the article was written months ago. However, it was an excellent base to help me see the distinct differences between hESCs and adult stem cells.

I found it interesting that scientists were expecting that hESCs were more likely to be rejected during transplant than adult stem cells. This does make sense though, adult stem cells come from one's own body, where as hESCs are foreign.

Also, I had never read anywhere else that adult stem cells are rare. I was under the assumption that they were everywhere! As it turns out, they are more difficult to find and harder to culture than hESCs. I also didn't know that adult stem cells can only be cultured into more of the original tissue that they were taken from. Where as hESCs can be cultured into any type of cell.

I'm pleased to have found this information, but still wary, it might not all be completely accurate. For example, they said hESCs were more likely to be rejected from the body, but hESCs also don't produce tumors like adult stem cells do.

Notes: difference between adult stem cells and hESCs 13

hESCs can be easily cultured, adult stem cells are rare and more limited

hESCs are pluripotent and can become any type of cell, adult stem cells can only be cultured into more of their original tissues

hESCs are easy to culture, adult stem cells are challenging to find in mature tissues

number of cells you can culture through adult stem cells are still limited. This is a challenge because mass amounts of cells are needed for stem cell therapies.

scientists are curious to see if hESCs will be rejected less during transplant than adult stem cells. they will be able to know after clinical trails are more developed since they have only recently been approved the the United State's FDA.

Thursday, January 28, 2010

Response: X Cell Center Website Blog 12

X Cell is actually a complete website about a particular private institute in Germany dedicated to stem cell research and treatment. I felt like this website gave me a lot of information and I will definitely be going back and digging deeper into the site. There were also many contacts given on that site that I will try to get in touch with soon for more information on the company and the research their company is doing.

I learned a lot of new information on what adult stem cells can treat. For example, I was unaware that Alzheimer's disease could be treated through stem cell therapy. I think it's amazing that I found a place where many of the treatments I've been researching are being put into action. I feel like reading through this website has been a mini break through because it's marking even more growth in the world of stem cell research and treatment. I find it strange that the things we are researching here in the states is being put into action in Germany. Why is that? Why don't we have this information yet? Why are we just getting the grants now? There are dozens of success stories on the X Cell website. One is a girl with autism was treated using stem cell therapies, and a great percentage of her symptoms improved. I can't wait for there to be opportunities like this here in the US.

Notes: X Cell Center Website Blog 12

X Cell is a regenerative medicine institute in Dusseldorf and Cologne, Germany.

Combines both stem cell therapy and stem cell research in one place.

Offers therapies for patients with degenerative diseases

They mostly treat:
Diabetes mellitus (type 1, 2 and sequelae)
Stroke
Spinal injuries
Multiple Sclerosis
Amyotrophic lateral sclerosis (ALS)
Parkinson's
Altzeimer's

Also treat:
arthritis
heart disease
eye disease
neuropathy
incontenence
Goals:
To provide stem cell therapies to their patients (adult stem cells)
And continue to improve their knowledge about stem cells

Started in 2007, and has successfully helped over 2400 patients

Treats patients with their own autologous adult stem cells, first private facility in the world licenced for this particular treatment.

Thursday, January 7, 2010

Response: Stem Cell Therapy Michaela Rodrigues 11

This article comes from a subscription I get sent to my e-mail. It's the Stem Cell Institute's subscription. They were re-capping, in this months edition, some of the most amazing stories that they've received this year. Michaela's story was amazing. The majority of the article was written by her parents. They gave their opinions on what the stem cell therapy has done for Michaela's health. Both parents are thrilled with the results. For Michaela to be able to stand is remarkable. They highly accredit this success to the stem cell injections Michaela has been receiving. I found this article to be a great read. It was from the perspective of someone dealing with stem cell therapy first hand. They're calling the shots for Michaela's treatments. The article was refreshing in comparison to other articles I've read that are just from an outside source retelling a story.

Michaela's parents have been immersed in Michaela's condition and the medical needs that come with it since Michaela's birth. They're highly knowledgeable about the medical care that Michaela has received. They're support for stem cell therapy is incredible, and I wish them the best of luck.

Notes: Stem Cell Therapy Michaela Rodrigues 11

Michaela Rodrigues is the only surviving twin who was born 16 weeks premature.
She suffers from cerebral palsy. Her condition was caused by too much oxygen and steroids in her system when she was first born and this led to some of her neurons being blocked.

The affects this has had on her include...
• she has difficulty holding onto objects. Her hands lock when holding and object, and holding onto anything makes her limbs shake. However with concentration she can stop the shaking.
• Michaela has a weak torso and requires support to keep her upright.
• Being startled also triggers her legs to shake.
• If she's left alone in her bed she will shake and turn over, face in the pillow, and not be able to turn back up without aide.

After recieving stem cells through an IV and stem cells through spinal injection, Just days after receiving the treatments Michaela was able to stand with both feet flat on the ground and also sit comfortably in a wheel chair for the first time ever.

Doctors had advised that Michaela received many drugs, Deep Brian Simulation, Botox, and Intrathecal Baclofen Pump to help with her condition. Michaela's parents, Wendy and Christopher, believe that if they had gone through with these treatments Michaela would be in worse shape than she is now. Both parents highly recommend that other parents of disabled children look into stem cell therapy for their children.

Sunday, January 3, 2010

Response: Stem Cell Therapy Reverses Blindness 10

I'm so pleased to hear that they have begun running human trials for stem cell research. Until now I had only been able to find articles saying that they were hoping to, or had been given permission to, run the trials. The incredible success of all 8 patients is a great step forward for stem cell research. Hopefully the success will help to gather more supporters and even more grants for stem cell, as well as hESC research.
I found this article very interesting as a follow up article. I had some background knowledge on scientists hoping to repair blindness through stem cell research from a previous article. The news that the trials were a success is very exciting. It's one thing to have a theory for what stem cells are capable of doing, and another to have it proven.
The contrast between the earlier article on stem cells repairing blindness, and the current article show the leaps and bounds that stem cell research is quickly making. The progression in the research seems to be mostly positive, and with new funding and loosened restriction, hopefully the research will be allowed to go even further.

Notes: Stem Cell Therapy Reverses Blindness 10

An experimental trial was conducted on 8 patients.
All patients had a form of blindness, and volunteered to be a part of the study.
One patient, Russell Turnball...
• injury due to chemical burns
• pain upon blinking
• clouded vision
• sensitive to light
• chemicals had burned his limbal cells in his cornea
What was done...
limal cells were taken from the other eye (which had not suffered chemical burns) and they used as a template to recreate artificial cells.
the artificial cells were then applied to "human amniotic membrane- a tissue that provides fetal support." After this was done scientists were able to surgically place the new cells over the damaged part of Russell Turnball's cornea.

The procedure was a success, and Russell Turnball's vision has been almost completely restored.

The 7 other patients experienced similar results. Their sight had been restored (for the most part) only 19 months after the procedure. This experiment was very successful.